FMD is evolving from a rare disease of renal arteries accounting for a minority of cases of secondary hypertension in young women, to a "systemic" vascular disease which can affect all arterial beds. In the UK, FMD was historically thought to carry a benign prognosis. As such research in this area has lagged behind. Yet, FMD can be associated with severe hypertension, ischaemic or haemorrhagic stroke, myocardial infarction and end stage renal diseases. It can lead to invasive procedures such as percutaneous angioplasty, reconstructive surgery, or intracranial aneurysm clipping. Thus, both the disease and its treatment can lead to significant morbidity and mortality.
This information day will aim to explain what FMD is, challenge previous misconceptions about FMD and highlight the latest work being undertaken by registries and research.